|
|
|
|
LEADER |
00000cam a2200000Ii 4500 |
001 |
SCIDIR_ocn869641793 |
003 |
OCoLC |
005 |
20231120111520.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
140201t19931993cau ob 001 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e rda
|e pn
|c EBLCP
|d OCLCQ
|d OPELS
|d N$T
|d E7B
|d OCLCQ
|d OCLCF
|d YDXCP
|d DEBSZ
|d OCLCQ
|d MERUC
|d DEBBG
|d OCLCQ
|d VLY
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1162128691
|
020 |
|
|
|a 9781483282305
|q (electronic bk.)
|
020 |
|
|
|a 1483282309
|q (electronic bk.)
|
020 |
|
|
|z 9780123649355
|
035 |
|
|
|a (OCoLC)869641793
|z (OCoLC)1162128691
|
050 |
|
4 |
|a QR185.8.C95
|b C98 1993eb
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.07/9
|2 23
|
245 |
0 |
0 |
|a Cytokine-induced pathology.
|n Part B,
|p Inflammatory cytokines, receptors, and diseases /
|c edited by G.W. Richter, Kim Solez.
|
246 |
3 |
0 |
|a Inflammatory cytokines, receptors, and diseases
|
264 |
|
1 |
|a San Diego :
|b Academic Press, Inc.,
|c [1993]
|
264 |
|
4 |
|c �1993
|
300 |
|
|
|a 1 online resource (xv, 232 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a International review of experimental pathology ;
|v volume 34, part B
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
8 |
|
|a Preface; Section I Pathology Induced by Inflammatory Cytokines; Chapter 1: Introduction; I Interferon-[gamma]; II Tumor Necrosis Factor; III Interleukin-8; Chapter 2: Pathophysiologic Alterations Induced by Tumor Necrosis Factor; Publisher Summary; I Introduction; II TNF-Induced Peripheral Blood Alterations; III Organ Injury Induced by TNF; IV Additional Toxicity of TNF; V Comparison of Endogenous and Exogenous TNF; VI Inhibition of Toxicity with Anti-TNF Antibody; VII Summary; VIII Acknowledgments ; Chapter 3: In Vitro and in Vivo Activity and Pathophysiology of Human Interleukin-8 and Related PeptidesPublisher Summary; I Introduction; II Induction and Formation; III Biological Activities; IV Biological Activities in Vitro; V Discussion; VI Summary; Chapter 4: Pathology of Recombinant Human Transforming Growth Factor-[beta]1 in Rats and Rabbits; Publisher Summary; I Introduction; II Experimental Results; III Discussion; IV Summary; Acknowledgments; Chapter 5: Pathology Induced by Leukemia Inhibitory Factor; Publisher Summary; I Introduction; II Pathology Induced by LIF; III Discussion ; IV SummaryChapter 6: Comparative Pathology of Recombinant Murine Interferon--[gamma] in Mice and Recombinant Human Interferon--[gamma] in Cynomolgus Monkeys; Publisher Summary; I Introduction; II Experimental Findings; III Discussion; IV Summary; Acknowledgments; Section II Cytokine Receptors; Chapter 7: Introduction to Cytokine Receptors: Structure and Signal Transduction; Publisher Summary; I Introduction; II Tumor Necrosis Factor Receptor Family; III The Hematopoietic Growth Factor Receptor Family; IV The Immunoglobulin Supergene Family; V Other Cytokine Receptors ; Chapter 8: Pharmacokinetic Parameters and Biodistribution of Soluble Cytokine ReceptorsPublisher Summary; I Introduction; II Methods of Pharmacokinetic and Biodistribution Analysis; III Soluble IL-1 Receptor; IV Soluble IL-4 Receptor; V Soluble TNF Receptors; VI Comparison of sTNF-R Fusion Protein to sIL-4R Fusion Protein; VII Summary; Acknowledgments; Chapter 9: Immunomodulation with Soluble IFN--[gamma] Receptor: Preliminary Study; Publisher Summary; I Introduction; II IFN--[gamma] Receptor; III Soluble IFN--[gamma]R; IV Immunogenicity and Pharmacokinetic Studies of Mouse Soluble IFN--[gamma]R ; V Modulation of Graft-Versushost Disease by Soluble MoIFN--[gamma]RVI Discussion; VII Summary; Chapter 10: TNF Receptor Distribution in Human Tissues; Publisher Summary; I Introduction; II Distribution of TNF-R in Lymphoid Tissues; III TNF-R Distribution in other Tissues; IV TNF-[alpha] Expression in Tissues; V Discussion; VI Summary; Section III Role of Cytokines in Disease; Chapter 11: Tumor Necrosis Factor/Cachectin as an Effector of T Cell-Dependent Immunopathology; Publisher Summary; I Introduction; II TNF Properties Relevant for Immunopathology; III Possible Role of TNF in the Immune Response ; IV Immunopathological Reactions Involving T Lymphocytes and TNF.
|
588 |
0 |
|
|a Print version record.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Cytokines.
|
650 |
|
0 |
|a Disease susceptibility.
|
650 |
|
0 |
|a Growth factors.
|
650 |
|
0 |
|a Immunotoxicology.
|
650 |
|
6 |
|a Cytokines.
|0 (CaQQLa)201-0165955
|
650 |
|
6 |
|a Pr�edisposition morbide.
|0 (CaQQLa)201-0061991
|
650 |
|
6 |
|a Facteurs de croissance.
|0 (CaQQLa)201-0012819
|
650 |
|
6 |
|a Immunotoxicologie.
|0 (CaQQLa)201-0120108
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Cytokines
|2 fast
|0 (OCoLC)fst00886268
|
650 |
|
7 |
|a Disease susceptibility
|2 fast
|0 (OCoLC)fst00895153
|
650 |
|
7 |
|a Growth factors
|2 fast
|0 (OCoLC)fst00948607
|
650 |
|
7 |
|a Immunotoxicology
|2 fast
|0 (OCoLC)fst00968050
|
700 |
1 |
|
|a Richter, G. W.,
|e editor.
|
700 |
1 |
|
|a Solez, Kim,
|d 1946-
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Cytokine-induced pathology. Part B, Inflammatory cytokines, receptors, and diseases
|z 9780123649355
|
830 |
|
0 |
|a International review of experimental pathology ;
|v volume 34, pt. B.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123649355
|z Texto completo
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/00747718/34/part/PB
|z Texto completo
|